House-passed legislation would ban the use of quality-adjusted life-years, a metric that has gained worldwide acceptance as a ...
As large corporate entities and financial investors accrue more power in health care, states considering reinvigorating an ...
The COVID-19 pandemic demonstrated that US hospital and health care systems were ill-prepared for the surge of patients who ...
This past fall, ubiquitous Medicare Advantage ads on television, radio, social media, and across the internet looked a little ...
We propose a transparent framework for CMS to implement Medicare drug price negotiation in a manner that results in credible, ...
A new health policy brief from Health Affairs, with support from the Robert Wood Johnson Foundation, is titled “Pillars, ...
Health Affairs' Jeff Byers interviews Jack Hoadley from Georgetown University about the final rule for the Medicare Advantage and Medicare Part D programs for 2025. Read the new Health Policy Brief on ...
Repurposing a Food and Drug Administration (FDA)-approved drug for a new use has been informally practiced for years. In fact ...
The A.C.C.E.S.S. AI Model is a framework for multidisciplinary stakeholders to collectively engage communities, identify ...
On April 26, 2024, the Department of Health and Human Services published a final rule to strengthen privacy protections for ...
In their article, Philip Gruppuso, MD, and Eli Adashi, MD, MS, highlight some important inequities that necessitate the Fair ...
Health Affairs' Editor-in-Chief Alan Weil interviews Alison Stuebe of University of North Carolina School of Medicine on her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback